Status:
COMPLETED
The Effects of Rhus Coriaria L. on Serum Lipid Levels of Patients With Hyperlipidemia
Lead Sponsor:
Shiraz University of Medical Sciences
Conditions:
Hyperlipidemias
Eligibility:
All Genders
20-65 years
Phase:
EARLY_PHASE1
Brief Summary
Coronary heart disease and stroke are two main causes of human deaths and is directly related to increased levels of plasma lipids.High total cholesterol and low high density lipoprotein cholesterol c...
Detailed Description
Rhus (Somagh) is found in temperate and tropical regions worldwide, often growing in areas of marginal agricultural capacity. Rhus is used as an herbal remedy in traditional medicine because of its as...
Eligibility Criteria
Inclusion
- Age: 20-65 years
- Serum triglyceride \>150mg/dl AND/OR total cholesterol \>= 240mg/dl
Exclusion
- Serum triglyceride \> 500 mg/dl
- Serum LDL-cholesterol at level which need drug treatment according to the patient risk categories (NCEP-ATP III)
- Diabetes mellitus
- Hypo. or hyperthyroidism
- Any systemic illnesses e.g. liver cirrhosis, acute or chronic renal failure, heart failure
- Use of drugs: OCPs, lipid lowering agents, thiazides
- Pregnancy
- Alcoholism
- History of allergic reaction to Somagh
Key Trial Info
Start Date :
December 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2015
Estimated Enrollment :
74 Patients enrolled
Trial Details
Trial ID
NCT02295293
Start Date
December 1 2014
End Date
May 1 2015
Last Update
June 7 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shahid Motahhari Clinic, Shiraz University of Medical Sciences
Shiraz, Fars, Iran